Movano Expands Go-To-Market Team with Daniel Amara VP of UX and UI and Jim Chambers VP of Digital Marketing and Growth

Former Google FitBit and Liteboxer talent join Movano as it prepares for commercialization of the Movano Ring

Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the expansion of its go-to-market leadership team with two strategic hires: Daniel Amara is joining as Vice President of User Experience (UX) and User Interface (UI) and Jim Chambers as Vice President of Digital Marketing & Growth. Both Daniel and Jim have extensive experience in design and digital growth strategy, which is expected to help accelerate the commercialization of Movano’s first product, the Movano Ring.

Daniel brings more than a decade of experience in UX design and launching products to the Movano team. In his most recent role as UX Lead for Google Fitbit, he successfully launched a number of award-winning products, including Fitbit Sense, Fitbit Versa III, and Fitbit Inspire. Prior to Fitbit, Daniel held various roles designing connected hardware-software products for brands such as Toshiba, Alpine, and Chevrolet, and also consulted for hardware-based startups with founders Ben and Hermione Way and Peter Thiel.  As Movano’s VP, UX and UI, Daniel will oversee the lifecycle of Movano’s products and work with the Company’s best-in-class design and engineering teams to identify new opportunities and product features that are important to Movano’s customer base.
Jim has over a decade of experience in growth and digital marketing that will be crucial for the direct-to-consumer launch of the Movano Ring. Most recently, he was Vice President, Growth Marketing at Liteboxer, an elite connected fitness company. In this role, Jim developed and led the company’s growth strategy, integrated multi-channel digital marketing campaigns to drive sales and executed successful launches of two new products: Liteboxer Virtual Reality in the US, Mexico and Canada, and Liteboxer Go in the US. Prior to joining Liteboxer, Jim was Senior Director of Global E-Commerce Sales & Marketing at Hydrow, Inc., a leading connected fitness rowing company. In this role, he set the overall growth strategy and metrics for sales and digital marketing in the US and UK, and led the team to deliver over 10 times sales growth from 2019 to 2020. As Movano’s VP, Digital Marketing and Growth, Jim will develop the company’s digital growth strategies through innovative ROI-based customer approaches and data-driven acquisition strategies.
“We know the key to the success of our wearable solution is largely dependent on creating a differentiated, intuitive and beautiful product, brand and consumer experience that’s compelling for users over the long term. We’ve brought Daniel and Jim on to drive our vision and elevate the Movano Ring to the next level,” said John Mastrototaro, CEO of Movano Inc. “As we progress toward launching our first commercial product, it’s crucial to have industry veterans leading our go-to-market strategy, and we feel so fortunate to have Daniel and Jim on our team.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.